FR3094378B1 - Traitement des maladies respiratoires avec la bacterie lactobacillus animalis - Google Patents

Traitement des maladies respiratoires avec la bacterie lactobacillus animalis Download PDF

Info

Publication number
FR3094378B1
FR3094378B1 FR1903364A FR1903364A FR3094378B1 FR 3094378 B1 FR3094378 B1 FR 3094378B1 FR 1903364 A FR1903364 A FR 1903364A FR 1903364 A FR1903364 A FR 1903364A FR 3094378 B1 FR3094378 B1 FR 3094378B1
Authority
FR
France
Prior art keywords
treatment
respiratory diseases
lactobacillus animalis
bacteria
animalis bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1903364A
Other languages
English (en)
Other versions
FR3094378A1 (fr
Inventor
Geanncarlo Lugo
Lucie Bernard
Olivier Neyrolles
Muriel Thomas
Philippe Langella
Aude Remot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Toulouse III Paul Sabatier
Institut National de Recherche pour lAgriculture lAlimentation et lEnvironnement
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Universite Toulouse III Paul Sabatier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Recherche Agronomique INRA, Universite Toulouse III Paul Sabatier filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1903364A priority Critical patent/FR3094378B1/fr
Priority to EP20715360.2A priority patent/EP3947747A1/fr
Priority to US17/593,910 priority patent/US20220162547A1/en
Priority to PCT/EP2020/058832 priority patent/WO2020201145A1/fr
Publication of FR3094378A1 publication Critical patent/FR3094378A1/fr
Application granted granted Critical
Publication of FR3094378B1 publication Critical patent/FR3094378B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention a pour objet l’utilisation de la bactérie Lactobacillus animalis dans le traitement des maladies respiratoires chez les humains tout comme chez les animaux. Il est notamment décrit une souche particulière de cette bactérie et des compositions pharmaceutiques la comprenant.
FR1903364A 2019-03-29 2019-03-29 Traitement des maladies respiratoires avec la bacterie lactobacillus animalis Active FR3094378B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1903364A FR3094378B1 (fr) 2019-03-29 2019-03-29 Traitement des maladies respiratoires avec la bacterie lactobacillus animalis
EP20715360.2A EP3947747A1 (fr) 2019-03-29 2020-03-27 Traitement des maladies respiratoires avec une bacterie du genre lactobacillus
US17/593,910 US20220162547A1 (en) 2019-03-29 2020-03-27 Treatment of respiratory diseases with a bacterium of the genus lactobacillus
PCT/EP2020/058832 WO2020201145A1 (fr) 2019-03-29 2020-03-27 Traitement des maladies respiratoires avec une bacterie du genre lactobacillus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1903364 2019-03-29
FR1903364A FR3094378B1 (fr) 2019-03-29 2019-03-29 Traitement des maladies respiratoires avec la bacterie lactobacillus animalis

Publications (2)

Publication Number Publication Date
FR3094378A1 FR3094378A1 (fr) 2020-10-02
FR3094378B1 true FR3094378B1 (fr) 2023-11-24

Family

ID=67810747

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1903364A Active FR3094378B1 (fr) 2019-03-29 2019-03-29 Traitement des maladies respiratoires avec la bacterie lactobacillus animalis

Country Status (4)

Country Link
US (1) US20220162547A1 (fr)
EP (1) EP3947747A1 (fr)
FR (1) FR3094378B1 (fr)
WO (1) WO2020201145A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3114970B1 (fr) * 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015111658B4 (de) 2015-07-17 2018-11-29 Capical Gmbh System, Verfahren und Computerprogramm zur kapazitiven Erfassung von elektrischen Biosignalen
US11141443B2 (en) * 2017-04-12 2021-10-12 The Uab Research Foundation Inhaled respiratory probiotics for lung diseases of infancy, childhood and adulthood
EP3723776A4 (fr) * 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions et méthodes pour supprimer des organismes pathogenes

Also Published As

Publication number Publication date
EP3947747A1 (fr) 2022-02-09
US20220162547A1 (en) 2022-05-26
FR3094378A1 (fr) 2020-10-02
WO2020201145A1 (fr) 2020-10-08

Similar Documents

Publication Publication Date Title
Johansson et al. Antibacterial effect of ozone on cariogenic bacterial species
MX2020001513A (es) Agentes de union a clec9a y su uso.
MA32226B1 (fr) Compositions et leurs procedes de preparation et d'utilisation
EA202190140A1 (ru) Соединения и способы для снижения экспрессии lrrk2
MA41060B1 (fr) Compositions comprenant des souches bactériennes
MA55434B1 (fr) Compositions comprenant des souches bactériennes
MA41010A (fr) Compositions comprenant des souches bactériennes
WO2017194782A3 (fr) Ciblage thérapeutique de structures non cellulaires
TN2015000168A1 (fr) Inhibiteurs de la tyrosine kinase de bruton
MA29931B1 (fr) Inhibiteurs de la proteine d'activation de la 5-lipoxygenase (flap)
TN2012000073A1 (fr) Derives des l-(piperidine-4-yl) pyrazole servant de modulateurs de gpr119
MX2020008208A (es) Agentes de unión a fibroblastos y uso de estos.
TNSN07401A1 (fr) Anticorps diriges contre le peptide amyloide-beta, et methodes pour leurs utilisations
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
MA30041B1 (fr) Immunoglobulines
MA46619B1 (fr) Anticorps anti-il-33 et leurs utilisations
NZ732241A (en) A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
MA45172B1 (fr) Arn modifié codant pour des polypeptides vegf-a, formulations et utilisations associées
RS52620B (en) THE USE OF CHITOSAN FOR THE TREATMENT OF INFLAMMATORY DISEASES OF NAILS
MA34670B1 (fr) Inhibiteurs de l'apoptose et leurs utilisations
MX2022003758A (es) Composiciones para el cuidado bucal que comprenden acido beta de lupulo y aminoacido.
MX2022005547A (es) Derivados terapeuticos de interleucina-22.
FR3094378B1 (fr) Traitement des maladies respiratoires avec la bacterie lactobacillus animalis
FR3073139B1 (fr) Composition ameliorant le bien-etre des animaux
WO2018033941A3 (fr) Compositions pharmaceutiques à base d'ibrutinib

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20201002

PLFP Fee payment

Year of fee payment: 3

CD Change of name or company name

Owner name: UNIVERSITE PAUL SABATIER TOULOUSE III, FR

Effective date: 20210215

Owner name: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULT, FR

Effective date: 20210215

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20210215

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5